Join the club for FREE to access the whole archive and other member benefits.

C. Thomas Caskey

Chief Medical Officer, Human Longevity Inc.

Chief Medical Officer

Dr. Thomas Caskey, MD, FACP, FACMG, FRSC is Chief Medical Officer for Human Longevity, Inc. He currently serves as Professor, Molecular & Human Genetics at the Baylor College of Medicine.

He served as the CEO of The Brown Foundation Institute of Molecular Medicine at UTHSC-Houston and held esteemed positions at the Human Genetics and Vaccines Discovery at Merck Research Laboratories, West Point, and served as President of the Merck Genome Research Institute.

Dr. Caskey is Board Certified in Internal Medicine, Medical Genetics, and Molecular Genetics with 25 years of patient care experience. He is a member of the National Academy of Sciences, Institute of Medicine (Chair, Board on Health Sciences Policy), Royal Society of Canada, past President: American Society of Human Genetics & Human Genome Organization, and Texas Academy of Medicine, Engineering and Science. He also is an editor of the Annual Reviews of Medicine.

Dr. Caskey received numerous academic and industry honors. His genetic research identified genetic basis of 25 major inheritable diseases and clarified the understanding of “anticipation” in triplet repeat diseases (Fragile X, myotonic dystrophy and over 25 others). His personal identification patent is the basis of worldwide application for forensic science and he is also a consultant to the FBI in forensic science.

Dr. Caskey is currently directing a program of Precision Medicine with Young Presidents Organization (YPO) co-sponsored by The Cullen Foundation for Higher Education. The program won the YPO International Award for most innovative education program. He is also a member of the Board of Metabolon, Inc. Recent publications address the utility of genome wide sequencing to preventive adult onset diseases. His current research focuses on the application of whole genome sequence and metabolomics of individuals toward the objective of disease risk and its prevention.

Visit website:


See also: Company Human Longevity - Health Intelligence Company

Details last updated 05-Feb-2020

C. Thomas Caskey News

Pre-mature deaths in adults may be prevented, shown by HLI's largest study

EurekAlert! - 27-Jan-2020

Made possible by early detection of disease and disease risks through whole genome sequencing